6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine

C112H132N26O13S3 — CID 158892222

IUPAC6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine
SMILESCc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cncc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1csc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc(OC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.c1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1
InChIInChI=1S/C23H28N6O2.2C23H27N5O3S.C22H25N5O3.C21H25N5O2S/c1-16-14-24-15-22(27-16)28-17-2-4-19(5-3-17)31-21-13-18(29-8-10-30-11-9-29)12-20-23(21)26-7-6-25-20;1-15-14-32-23(26-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-6-25-22(26-7-1)30-18-4-2-17(3-5-18)29-20-15-16(27-10-12-28-13-11-27)14-19-21(20)24-9-8-23-19;1-3-17(4-2-15(1)25-21-24-7-12-29-21)28-19-14-16(26-8-10-27-11-9-26)13-18-20(19)23-6-5-22-18/h6-7,12-15,17,19H,2-5,8-11H2,1H3,(H,27,28);2*6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29);1,6-9,14-15,17-18H,2-5,10-13H2;5-7,12-15,17H,1-4,8-11H2,(H,24,25)
InChIKeyJEJNJVXQIXANQW-UHFFFAOYSA-N
MW2146.66 g/mol
LogP16.82
Rot. Bonds25

About 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine

6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine (PubChem CID 158892222) has the molecular formula C112H132N26O13S3 and a molecular weight of 2146.66 g/mol. Its IUPAC name is 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine.

Molecular Properties

Compound Name6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine
PubChem CID158892222
Molecular FormulaC112H132N26O13S3
Molecular Weight2146.66 g/mol
Exact Mass2144.96
IUPAC Name6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine
SMILESCc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cncc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1csc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc(OC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.c1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1
InChIInChI=1S/C23H28N6O2.2C23H27N5O3S.C22H25N5O3.C21H25N5O2S/c1-16-14-24-15-22(27-16)28-17-2-4-19(5-3-17)31-21-13-18(29-8-10-30-11-9-29)12-20-23(21)26-7-6-25-20;1-15-14-32-23(26-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-6-25-22(26-7-1)30-18-4-2-17(3-5-18)29-20-15-16(27-10-12-28-13-11-27)14-19-21(20)24-9-8-23-19;1-3-17(4-2-15(1)25-21-24-7-12-29-21)28-19-14-16(26-8-10-27-11-9-26)13-18-20(19)23-6-5-22-18/h6-7,12-15,17,19H,2-5,8-11H2,1H3,(H,27,28);2*6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29);1,6-9,14-15,17-18H,2-5,10-13H2;5-7,12-15,17H,1-4,8-11H2,(H,24,25)
InChIKeyJEJNJVXQIXANQW-UHFFFAOYSA-N
XLogP16.82
TPSA419.12 Ų
H-Bond Donors4
H-Bond Acceptors40
Rotatable Bonds25
Heavy Atoms154
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002146.66
LogP ≤ 516.82
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1040

Analyze 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine?
The IUPAC name of 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine (CID 158892222) is 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine.
What is the SMILES notation for 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine?
The canonical SMILES for 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine is Cc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cncc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1csc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc(OC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.c1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.
What is the InChIKey of 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine?
The InChIKey is JEJNJVXQIXANQW-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H28N6O2.2C23H27N5O3S.C22H25N5O3.C21H25N5O2S/c1-16-14-24-15-22(27-16)28-17-2-4-19(5-3-17)31-21-13-18(29-8-10-30-11-9-29)12-20-23(21)26-7-6-25-20;1-15-14-32-23(26-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19;1-6-25-22(26-7-1)30-18-4-2-17(3-5-18)29-20-15-16(27-10-12-28-13-11-27)14-19-21(20)24-9-8-23-19;1-3-17(4-2-15(1)25-21-24-7-12-29-21)28-19-14-16(26-8-10-27-11-9-26)13-18-20(19)23-6-5-22-18/h6-7,12-15,17,19H,2-5,8-11H2,1H3,(H,27,28);2*6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29);1,6-9,14-15,17-18H,2-5,10-13H2;5-7,12-15,17H,1-4,8-11H2,(H,24,25).
What are the key properties of 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine?
6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine has a molecular weight of 2146.66 g/mol, XLogP of 16.82, 25 rotatable bonds, 4 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazin-2-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;4-[8-(4-pyrimidin-2-yloxycyclohexyl)oxyquinoxalin-6-yl]morpholine is sourced from PubChem (CID 158892222), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).